Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumors
Silvia Nicolini, Lisa Bodei, Alberto Bongiovanni, Maddalena Sansovini, Ilaria Grassi, Toni Ibrahim, Manuela Monti, Paola Caroli, Anna Sarnelli, Danila Diano, Valentina Di Iorio, Chiara Maria Grana, Corrado Cittanti, Federica Pieri, Stefano Severi, Giovanni Paganelli
Topics & Concepts
CapecitabineMedicineNeuroendocrine tumorsInternal medicineGastro-Neuroendocrine tumourNuclear medicineOncologyGastroenterologyCancerColorectal cancerDiseaseRefluxNeuroendocrine Tumor Research AdvancesPancreatic and Hepatic Oncology ResearchGastrointestinal Tumor Research and Treatment